Andersen SL, Oloo AJ, Gordon DM, Aleman G, Berman J, Tang DB, Dunne
MW, Shanks GD. A double blinded, placebo controlled trial of azithromycin compared to doxyctckube for malaria prophylaxis in
western Kenya. Clinical Inf Dis; 1998: 26: 146150.
Berman-JD; Badaro-R;Thakur-CP; Wasunna-KM; Behbehani-K; Davidson-R;
Kuzoe-F; Pang-L; Weerasuriya-K; Bryceson-AD. (1998). Efficacy and
safety of liposomal amphotericin B (AmBisome) for visceral
leishmaniasis in endemic developing countries.
Bull-World-Health-Organ.76(1): 25-32.
Broadhurst LE, Kelly DJ, Chan C.T;, Smoak BL, Brundage JF, McClain
JB, Miller RN. Laboratory evaluation of a dot blot enzyme
immunoassay for serological confirmation of illness due to Rickettsia conorii. Am J Trop Med Hyg 1998; 58:786-9
Edstein MD, Bahr S, Kotecka, B, Shanks GD, Rieckmann KH. In vitro
activity of the biguanide, PS-15, and its metabolite, WR99210
against cycloguanil, resistant Plasmodium falciparum isolates from
Thailand. Ant micro Agents Chemo 1998; 41:2300-01. Fried-M;
Duffy-PE. (1998 Mar). Maternal malaria and parasite adhesion. J-
Mol-Med. 76(3-4): 162-71
Fried-m; Muga-RO; Misore-RO; Duffy-PE.(1998Mar1). Malaria elicits
type1 cytokines in the human placenta: IFN-gamma and TNF-alpha
associated with pregnancy outcomes. J-Immunol.160(5):2523-30
Fried-M; Nosten-F; Brockman-A; Brabin-BJ; Duffy-PE, (1998). Maternal
antibodies block malaria. Nature, Vol. 395.
Gambel JM, Brundage JF, Burge RJ, DeFraites RF, Smoak BL, Wirtz RA.
Survey of US Army soldiers' knowledge, attitudes, and practices
regarding personal protection measures to prevent arthropod-related
diseases and nuisance bites. Mil Med in press
Garcia GE, Wirtz RA, Barr JR, Woolfit A & Rosenberg R (1998). Xanthurenic acid induces gametogenesis in Plasmodium, the malaria
parasite. Journal of Biological Chemistry, 273: 12003-12005.
Iversen-ER;Colding-H;Peterson-L; Ngetich-R;Shanks-GD.(1998Jan-Feb). Epidemic
Shigella dysenterae in Mumias,Western Kenya.
TRANS-R-SOC-TROP-MED-HYG.92(1):30-1.
J. A. Stoute et al. Long Term Efficacy and Immune Responses
Following Immunization with the RTS,S Malaria Vaccine. J Infect Dis
178(4):1139-1144, 1998.José A. Stoute and W. Ripley Ballou. Malaria
Vaccines: Current Status. BioDrugs. 10(2):123-136, 1998.
Kanesa, thasan N, Chang G-J J, Smoak BL, Magill A, Burrous MJ, Hoke
CH. Molecular and epiderniologic analysis of dengue virus isolates
from Somalia. Emerging infectious Diseases 1998; 4: 299-303.
Kariuki-MM;Kiairia-JK;Mulaa-FK;Wasunna-KM;Martin-SK.(1998). Plasmodium
Falcipurum: Purification of the variuos gametocyte developmental
stages from in vitro-cultivated parasite.Am-J-Trop-Med- Hyg.
59(4):505-508.
Kurtis-JD., Koros-JK, Duffy-PE; Green-MD. (1998 Apr 1). Malaria
prevention for travelers [letter]. JAMA. 279(13): 990- 1.
Luckhart S, Vodovotz Y, Cui L & Rosenberg R (1998). The mosquito
Anopheles stephensi limits malaria parasite development with
inducible synthesis of nitric oxide. Proc Natl Acad Sci USA, 95:
5700-5705.
Malakooti MA, Biomndo K, Shanks GD. Re-emergence of epidemic
highland malaria in western Kenya. J Emerging Infect Dis 1998 4:(4).
Martin-SK; Thuita-Harun-L; Adoyo-Adoyo-M; Wasunna-KM. (1998). A
diagnostic ELISA for visceral leishmania based on antigen from media
conditioned by Leishmania donovani promastigotes. Annals of Tropical
Medicine& Parasitolooy. 92(5)~ 571577.
Masinde, G. L.,Krogstad, D. J.,Gordon, D. M.,
and Duffy, P. E., 1998. Immunization
with SPf66 and subsequent infection with
homologous and heterologous Plasmodium
falciparum parasites.
Am.J.Trop.Med.Hyg. 59: 600-605.
Mason-CJ; Kitsiripornchai-S; Markowitz-LE, Chanbancherd-P,
Supapongse-T, Jugsudee-A; Sirisopana-N; Chuenchitra-C; Torugsa-K,
VanCott-TC, Michael-RA, Nitayaphan-S; (1998)Nationwide
surveillance of HIV-1 prevalence and subtype in young Thai
men. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 19:165-173.
Shanks- GD, Karwacki JJ, (1998). Malaria in Preventive Medicine:
Mobilization and Deployment Textbook of Millitary Medicine Series
(in press)
Shanks GD, Gordon DM, Klotz FW, Aleman GM, Oloo AJ, Sadie D, Scott
TR. Efficacy and safety of atovaquone/proquanil for suppressive
prophylaxis against plasmodium falcipurum Malaria. Clinical Infect
Dis 1998(in press).
Smoak BL, et al. Centers for Disease Control and Prevention. Rift
Valley Fever, East Africa, 1997-1998. MMWR 1998; 47: 261-4.
Smoak-BL et al., (1998). Rift Valley Fever - East Africa,
1997-1998. Mobidity and Mortality Weekly Report, 47: 261-264.
Shanks GD.(1998). Possible options for malaria chemoprophylaxis on
the horizon. Journal of Travel Medicine, Vol.6.S31
Waitumbi-j, Warburg-A (1998). Phlebotomus papatasi saliva inhibits
protein phosphatase activity and nitric oxide production by murine
macrophages. Infection and immunity, 1534-1537.
Waitumbi JN, Opollo MO, Muga RO, Misore AO, Stoute JA. Red cell
surface changes and erythrophagocytosis in children with severe
plasmodium falciparum anemia.
Blood. 2000 Feb 15;95(4):1481-6.